Description
OPTILITE ANALYZER, REAGENTS
First action · last action
2025-10-24 · 2025-10-24
Transactions
1
First transaction's obligation
$169,910
Base + all options value (sum of deltas)
$169,910
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25222D0060
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-10-24+$169,910= $169,910
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-10-24 | +$169,910 | $169,910 | OPTILITE ANALYZER, REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ETZEQNG96NN5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0395 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $69,423 | FY2026 |
| 36C24826N0254 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $74,121 | FY2026 |
| 36C25026F0294 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $183,301 | FY2026 |
| 36C24126N0140 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $276,000 | FY2026 |
| 36C24126A0010 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26226N0172 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $428,607 | FY2026 |
Other recipients under 6640 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226P0549 | AGILENT TECHNOLOGIES INC | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $15,156 | FY2026 |
| 36C25226F0374 | GOVERNMENT SCIENTIFIC SOURCE INC | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $26,123 | FY2026 |
| 36C25226N0463 | ROCHE DIAGNOSTICS CORPORATION | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $114,960 | FY2026 |
| 36C25226D0033 | ROCHE DIAGNOSTICS CORPORATION | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $0 | FY2026 |
| 36C25226F0289 | THE BAKER COMPANY, INC. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $30,223 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25226N0129_3600_36C25222D0060_3600 · retrieved 2026-09-26.